# Photoallergy Potential of Dapsone Gel in Healthy Volunteers

> **NCT02117739** · PHASE1 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** dapsone gel
- **DRUG:** dapsone gel vehicle

## Key facts

- **NCT ID:** NCT02117739
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117739, "Photoallergy Potential of Dapsone Gel in Healthy Volunteers". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT02117739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*